Ambulerosp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Suspended
Registry date
2020-12-28
Share capital
5 300,00 PLN
Registered address
ul. Szafarnia 11/F8, 80-755 Gdańsk, Poland
Electronic delivery address
AE:PL-43311-87535-WRSBE-22

Financials

Revenue history (in k)

Filing timeliness

1 of 5 financial statements was filed late (for 2021, 81 days late).

  • 202530/06/2026
  • 202410/07/2025
  • 202302/07/2024
  • 202207/07/2023
  • 202104/10/2022
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 8.55kMedianUSD 55.35kAverageUSD 2.71m
Net profit
This companyUSD 7.93kMedianUSD -1.27kAverageUSD -92.09k
Operating costs
This companyUSD 437.22MedianUSD 66.19kAverageUSD 2.67m
Assets
This companyUSD 238.69kMedianUSD 133.95kAverageUSD 3.03m

Authorized Representatives

Adam Kruszewski – Management Board Member

Manner of representation

Each member of the management board independently.

Supervisory board

Artur Płonowski – Supervisory Board Member
Randy John Berholtz – Supervisory Board Member
Robert Leo Buchanan – Supervisory Board Member

Ownership

OwnerSharesShare valueStake
Ambulero, Inc.
52$1,404.6598.1132%
Others
1$27.011.8868%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2023-05-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Change history

DateEvent
2026-08-03Business suspended
2026-08-02Business resumed
2024-08-01Business suspended
2021-06-14Address change
2021-06-14Share capital change

FAQ

Last updated: 2026-08-06